论文部分内容阅读
替尼泊甙 (teniposide,T)是鬼臼毒素的半合成衍生物。我院肿瘤科 1996～ 1997年参加了由中国医学科学院牵头 ,北京制药工业研究所研制的国产替尼泊甙 (T)临床验证。目的是评价 T治疗肺癌的临床疗效及不良反应 ,与进口 VM2 6(Vumon,V)进行随机对比研究。对象与方法选择经病理或
Teniposide (T) is a semisynthetic derivative of podophyllotoxin. In our hospital oncology from 1996 to 1997 participated in by the Chinese Academy of Medical Sciences led by Beijing Institute of Pharmaceutical Industry developed domestic teniposide (T) clinical validation. The purpose is to evaluate the clinical efficacy and adverse reactions of T in the treatment of lung cancer and to conduct a randomized comparison study with imported VM2 6 (Vumon, V). Object and method of choice by pathology or